Skip to Content

Rosetta Genomics Ltd ROSGQ

Morningstar Rating
$0.00 0.00 (99.00%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ROSGQ is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$4.43
Uncertainty
Extreme
1-Star Price
$4.64
5-Star Price
$4.22
Economic Moat
Cnx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ROSGQ is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.04
Market Cap
$5.93
Volume/Avg
2,171 / 2,758

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
86

Valuation

Metric
ROSGQ
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
ROSGQ

Financial Strength

Metric
ROSGQ
Quick Ratio
0.85
Current Ratio
2.09
Interest Coverage
Quick Ratio
ROSGQ

Profitability

Metric
ROSGQ
Return on Assets (Normalized)
−93.61%
Return on Equity (Normalized)
−161.02%
Return on Invested Capital (Normalized)
−148.92%
Return on Assets
ROSGQ

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncSxp$191.4 Bil
DHR
Danaher CorpMgcvnx$164.1 Bil
IDXX
IDEXX Laboratories IncTtblj$42.9 Bil
IQV
IQVIA Holdings IncHcqxbw$39.5 Bil
A
Agilent Technologies IncNghkc$37.6 Bil
MTD
Mettler-Toledo International IncQvgftf$23.9 Bil
ICLR
Icon PLCNcpjcgm$21.9 Bil
LH
Laboratory Corp of America HoldingsLgrqp$18.8 Bil
ILMN
Illumina IncNffrrl$18.2 Bil
WAT
Waters CorpXkhdx$17.1 Bil